SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Vulcan Inc – ‘SC 13G/A’ on 2/9/01 re: Pathogenesis Corp

On:  Friday, 2/9/01, at 4:47pm ET   ·   Accession #:  927087-1-500017   ·   File #:  5-45497

Previous ‘SC 13G’:  ‘SC 13G/A’ on 2/9/01   ·   Next:  ‘SC 13G/A’ on 2/9/01   ·   Latest:  ‘SC 13G/A’ on 4/1/04

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/09/01  Vulcan Inc                        SC 13G/A               1:11K  Pathogenesis Corp                 Foster Pepper PLLC/FA

Amendment to Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Schedule 13 G Amendment                                8     27K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
4Item 1 (a). Name of Issuer: Pathogenesis Corporation
"Item 1 (b). Address of Issuer's Principal Executive Offices:
"Item 2 (a). Name of Person Filing: Paul G. Allen and Vulcan Ventures Incorporated
"Item 2 (b). Address of Principal Business Office or, if none, Residence:
"Item 2 (d). Title of Class of Securities: Common Stock, par value $0.001 per share
"Item 2 (e). CUSIP Number: 70321E104
"Item 3. If this Statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not applicable
"Item 4. Ownership
"Item 5. Ownership of Five Percent or Less of a Class
5Item 6. Ownership of More Than Five Percent on Behalf of Another Person
"Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
"Item 8. Identification and Classification of Members of the Group
"Item 9. Notice of Dissolution of Group
"Item 10. Certification
SC 13G/A1st Page of 8TOCTopPreviousNextBottomJust 1st
 

----------------------------- OMB APPROVAL ----------------------------- OMB Number: 3235-0145 Expires: October 31, 2002 Estimated average burden Hours per response.... 14.90 ----------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2) PATHOGENESIS CORPORATION ------------------------ (Name of Issuer) Common Stock ------------------------------ (Title of Class of Securities) 70321E104 ------------------------------ (CUSIP Number) December 31, 2000 --------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) William D. Savoy Lucas D. Schenck 505 Union Station Foster Pepper & Shefelman PLLC 505 Fifth Avenue, Suite 900 1111 Third Avenue, Suite 3400 Seattle, Washington 98104 Seattle, Washington 98101 (206) 342-2000 (206) 447-4400 --------------------------------------------------------------------- (Name, Address and Telephone Number of Persons Authorized to Receive Notices and Communications) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
SC 13G/A2nd Page of 8TOC1stPreviousNextBottomJust 2nd
------------------------- ------------------------------ CUSIP NO. 70321E104 13G Page 2 of 8 Pages ------------------------- ------------------------------ -------- ----------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Paul G. Allen -------- ----------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] -------- ----------------------------------------------------------------------- 3 SEC USE ONLY -------- ----------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America -------- ----------------------------------------------------------------------- ----- ----------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF -0- shares SHARES ----- ----------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH -0- shares REPORTING ----- ----------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH -0- shares ----- ----------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- shares -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- shares -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT!
SC 13G/A3rd Page of 8TOC1stPreviousNextBottomJust 3rd
------------------------- ------------------------------ CUSIP NO. 70321E104 13G Page 3 of 8 Pages ------------------------- ------------------------------ -------- ----------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Vulcan Ventures Incorporated -------- ----------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] -------- ----------------------------------------------------------------------- 3 SEC USE ONLY -------- ----------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Washington -------- ----------------------------------------------------------------------- ----- ----------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF -0- shares SHARES ----- ----------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH -0- shares REPORTING ----- ----------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH -0- shares ----- ----------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- shares -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- shares -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO --------------------------------------------------------------------------------
SC 13G/A4th Page of 8TOC1stPreviousNextBottomJust 4th
Item 1 (a). Name of Issuer: Pathogenesis Corporation Item 1 (b). Address of Issuer's Principal Executive Offices: 201 Elliott Avenue West Seattle, Washington 98119 Item 2 (a). Name of Person Filing: Paul G. Allen and Vulcan Ventures Incorporated Item 2 (b). Address of Principal Business Office or, if none, Residence: 505 Union Station, 505 Fifth Avenue, Suite 900 Seattle, Washington 98104 Item 2 (c). Citizenship:Paul G. Allen is a citizen of the United States of America. Vulcan Ventures Incorporated is a corporation organized under the laws of the State of Washington. Item 2 (d). Title of Class of Securities: Common Stock, par value $0.001 per share Item 2 (e). CUSIP Number: 70321E104 Item 3. If this Statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not applicable. Item 4. Ownership (a) Amount Beneficially Owned:-0- shares (b) Percent of Class: 0% (c) Number of Shares as to which Such Person has: (i) sole power to vote or to direct the vote -0- shares (ii) shared power to vote or to direct the vote -0- shares (iii) sole power to dispose or to direct the disposition of -0- shares (iv) shared power to dispose or to direct the disposition of -0- shares Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Page 4 of 8
SC 13G/A5th Page of 8TOC1stPreviousNextBottomJust 5th
Item 6. Ownership of More Than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification Not applicable.
SC 13G/A6th Page of 8TOC1stPreviousNextBottomJust 6th
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. VULCAN VENTURES INCORPORATED February 8, 2001 By: /s/ William D. Savoy ----------------------------------------- William D. Savoy, Vice President February 8, 2001 * --------------------------------------------- Paul G. Allen *By: /s/ William D. Savoy ----------------------------------------- William D. Savoy as Attorney-in Fact for Paul G. Allen pursuant to a Power of Attorney filed on August 30, 1999, with the Schedule 13G of Vulcan Ventures Incorporated and Paul G. Allen for Pathogenesis, Inc. and incorporated herein by reference. Page 6 of 8
SC 13G/A7th Page of 8TOC1stPreviousNextBottomJust 7th
EXHIBIT INDEX Exhibit Description ------- ----------- 99.1 Joint Filing Agreement Page 7 of 8
SC 13G/ALast Page of 8TOC1stPreviousNextBottomJust 8th
EXHIBIT 99.1 Joint Filing Agreement ---------------------- We, the signatories of the statement to which this Joint Filing Agreement is attached, hereby agree that such statement is filed, and any amendments thereto filed by either or both of us will be filed, on behalf of each of us. Dated: February 8, 2001. VULCAN VENTURES INCORPORATED By: /s/ William D. Savoy ----------------------------------------- William D. Savoy, Vice President * --------------------------------------------- Paul G. Allen *By: /s/ William D. Savoy ----------------------------------------- William D. Savoy as Attorney-in Fact for Paul G. Allen pursuant to a Power of Attorney filed on August 30, 1999, with the Schedule 13G of Vulcan Ventures Incorporated and Paul G. Allen for Pathogenesis, Inc. and incorporated herein by reference. Page 8 of 8

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13G/A’ Filing    Date First  Last      Other Filings
10/31/021
Filed on:2/9/01SC 13G/A
2/8/0168
12/31/0015
8/30/9968SC 13G
 List all Filings 
Top
Filing Submission 0000927087-01-500017   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 7:48:08.2am ET